BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 10849365)

  • 1. Recruitment of SHP-1 protein tyrosine phosphatase and signalling by a chimeric T-cell receptor-killer inhibitory receptor.
    Christensen MD; Geisler C
    Scand J Immunol; 2000 Jun; 51(6):557-64. PubMed ID: 10849365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells.
    Yusa S; Catina TL; Campbell KS
    J Immunol; 2002 May; 168(10):5047-57. PubMed ID: 11994457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential roles of N- and C-terminal immunoreceptor tyrosine-based inhibition motifs during inhibition of cell activation by killer cell inhibitory receptors.
    Bruhns P; Marchetti P; Fridman WH; Vivier E; Daëron M
    J Immunol; 1999 Mar; 162(6):3168-75. PubMed ID: 10092767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reconstitution of killer cell inhibitory receptor-mediated signal transduction machinery in a cell-free model system.
    Cho HI; Park CG; Kim J
    Arch Biochem Biophys; 1999 Aug; 368(2):221-31. PubMed ID: 10441372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KIR2DL5 can inhibit human NK cell activation via recruitment of Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2).
    Yusa S; Catina TL; Campbell KS
    J Immunol; 2004 Jun; 172(12):7385-92. PubMed ID: 15187115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2) can play a direct role in the inhibitory function of killer cell Ig-like receptors in human NK cells.
    Yusa S; Campbell KS
    J Immunol; 2003 May; 170(9):4539-47. PubMed ID: 12707331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SHP-1/immunoreceptor tyrosine-based inhibition motif-independent inhibitory signalling through murine natural killer cell receptor Ly-49A in a transfected B-cell line.
    Motoda K; Takata M; Kiura K; Nakamura I; Harada M
    Immunology; 2000 Jul; 100(3):370-7. PubMed ID: 10929060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major histocompatibility complex class I molecules modulate activation threshold and early signaling of T cell antigen receptor-gamma/delta stimulated by nonpeptidic ligands.
    Carena I; Shamshiev A; Donda A; Colonna M; Libero GD
    J Exp Med; 1997 Nov; 186(10):1769-74. PubMed ID: 9362537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD5 negatively regulates the T-cell antigen receptor signal transduction pathway: involvement of SH2-containing phosphotyrosine phosphatase SHP-1.
    Perez-Villar JJ; Whitney GS; Bowen MA; Hewgill DH; Aruffo AA; Kanner SB
    Mol Cell Biol; 1999 Apr; 19(4):2903-12. PubMed ID: 10082557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B.
    Wang LL; Blasioli J; Plas DR; Thomas ML; Yokoyama WM
    J Immunol; 1999 Feb; 162(3):1318-23. PubMed ID: 9973385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adhesion to target cells is disrupted by the killer cell inhibitory receptor.
    Burshtyn DN; Shin J; Stebbins C; Long EO
    Curr Biol; 2000 Jun; 10(13):777-80. PubMed ID: 10898979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conserved residues amino-terminal of cytoplasmic tyrosines contribute to the SHP-1-mediated inhibitory function of killer cell Ig-like receptors.
    Burshtyn DN; Lam AS; Weston M; Gupta N; Warmerdam PA; Long EO
    J Immunol; 1999 Jan; 162(2):897-902. PubMed ID: 9916713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential.
    Faure M; Long EO
    J Immunol; 2002 Jun; 168(12):6208-14. PubMed ID: 12055234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine.
    Okazaki T; Maeda A; Nishimura H; Kurosaki T; Honjo T
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13866-71. PubMed ID: 11698646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of antigen-receptor signaling by Platelet Endothelial Cell Adhesion Molecule-1 (CD31) requires functional ITIMs, SHP-2, and p56(lck).
    Newman DK; Hamilton C; Newman PJ
    Blood; 2001 Apr; 97(8):2351-7. PubMed ID: 11290597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative signaling pathways of the killer cell inhibitory receptor and Fc gamma RIIb1 require distinct phosphatases.
    Gupta N; Scharenberg AM; Burshtyn DN; Wagtmann N; Lioubin MN; Rohrschneider LR; Kinet JP; Long EO
    J Exp Med; 1997 Aug; 186(3):473-8. PubMed ID: 9236201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Src homology 2 domain-containing protein-tyrosine phosphatases, SHP-1 and SHP-2, are required for platelet endothelial cell adhesion molecule-1/CD31-mediated inhibitory signaling.
    Henshall TL; Jones KL; Wilkinson R; Jackson DE
    J Immunol; 2001 Mar; 166(5):3098-106. PubMed ID: 11207261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells.
    Avril T; Floyd H; Lopez F; Vivier E; Crocker PR
    J Immunol; 2004 Dec; 173(11):6841-9. PubMed ID: 15557178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Docking protein Gab2 is phosphorylated by ZAP-70 and negatively regulates T cell receptor signaling by recruitment of inhibitory molecules.
    Yamasaki S; Nishida K; Hibi M; Sakuma M; Shiina R; Takeuchi A; Ohnishi H; Hirano T; Saito T
    J Biol Chem; 2001 Nov; 276(48):45175-83. PubMed ID: 11572860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The paired Ig-like receptor PIR-B is an inhibitory receptor that recruits the protein-tyrosine phosphatase SHP-1.
    Bléry M; Kubagawa H; Chen CC; Vély F; Cooper MD; Vivier E
    Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2446-51. PubMed ID: 9482905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.